GenAI not yet strategic priority with insurers still in early experimentation phase: Oxbow
Despite most specialty insurers and reinsurers seeing generative AI technology as transformational in the longer term, progress is being held back by other strategic objectives, according to an Oxbow Partners report.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below